Pfizer Declares Third-Quarter 2025 Dividend
1. Pfizer declared a quarterly cash dividend of $0.43 per share. 2. The dividend will be paid on September 2, 2025. 3. This marks the 347th consecutive quarterly dividend for Pfizer.
1. Pfizer declared a quarterly cash dividend of $0.43 per share. 2. The dividend will be paid on September 2, 2025. 3. This marks the 347th consecutive quarterly dividend for Pfizer.
Consistent dividend payments reflect financial stability and investor confidence, enhancing PFE's attractiveness.
The announcement showcases Pfizer's commitment to returning value to shareholders, crucial for investment sentiments.
Regular dividends can signify a robust financial outlook, benefiting long-term shareholders, similar to historical trends.
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2025 dividend on the company’s common stock, payable September 2, 2025, to holders of the Common Stock of record at the close of business on July 25, 2025. The third-quarter 2025 cash dividend will be the 347th consecutive quarterly dividend paid by Pfizer.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Category: Financial